CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Heart Rate Variability, Vagus Nerve and Cancer
- Status
- TERMINATED
- Phase
- NA
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer
- Status
- TERMINATED
- Phase
- NA
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients
- Status
- UNKNOWN
- Phase
- PHASE1
A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.
- Status
- COMPLETED
- Phase
- N/A
Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
- Status
- UNKNOWN
- Phase
- N/A
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
- Status
- RECRUITING
- Phase
- NA
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
- Status
- SUSPENDED
- Phase
- PHASE2
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
- Status
- COMPLETED
- Phase
- N/A